Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Equity Transactions (Details)

v3.21.2
Equity Transactions (Details) - USD ($)
$ / shares in Units, $ in Millions
1 Months Ended
Jun. 18, 2021
Apr. 07, 2021
Jan. 06, 2021
Jun. 03, 2020
Apr. 29, 2020
Apr. 30, 2021
Sep. 30, 2021
Dec. 31, 2020
Subsidiary, Sale of Stock [Line Items]                
Common stock, par value (in dollars per share)             $ 0.001 $ 0.001
Trapelo Health                
Subsidiary, Sale of Stock [Line Items]                
Shares of common stock issued as consideration (in shares)   597,712       597,712    
Private Placement                
Subsidiary, Sale of Stock [Line Items]                
Shares sold in offering (in shares) 4,444,445              
Offering price per share (in dollars per share) $ 45.00              
Net proceeds of common stock $ 189.9              
Payments of equity issue costs $ 10.1              
Common Stock Offering                
Subsidiary, Sale of Stock [Line Items]                
Shares sold in offering (in shares)     4,081,632   4,400,000      
Offering price per share (in dollars per share)     $ 49.00   $ 28.50      
Net proceeds of common stock     $ 189.9   $ 117.9      
Payments of equity issue costs     $ 10.1   $ 7.5      
Common stock, par value (in dollars per share)     $ 0.001   $ 0.001      
Option period (in days)         30 days      
Over-Allotment Option                
Subsidiary, Sale of Stock [Line Items]                
Shares sold in offering (in shares)     612,244 351,500 660,000      
Net proceeds of common stock     $ 28.4 $ 9.4        
Payments of equity issue costs     $ 1.6 $ 0.6        
Option period (in days)     30 days